Search
Close this search box.
RESEARCH & THOUGHTS

Perspectives Shaping Clinical Development

Discover engaging resources driving the conversation forward and on-demand demo videos showcasing the very solutions forming the future of our field.

Filter
View All
Guides
Case Studies
White Papers
Research Papers
Blogs
Demo Videos
Infographics
Fact Sheets
Your Journey to Adaptive Site Monitoring
Meet SPOT: Transforming Site Monitoring Practices with Adaptive Intelligence
A New Era of Automation: Improving Efficiency & Outcomes with Intelligent Medical Coding
Site Profile & Oversight Tool (SPOT)
Business Intelligence (BI)
Central Statistical Monitoring
Duplicate Patients
Key Risk Indicators (KRIs)
Patient Profiles
Quality Tolerance Limits (QTLs)
Risk Assessment & Mitigation
Signals & Actions Tracker
The Ultimate Guide to Risk-Based Quality Management
Empower Clinical Trial Teams with ML
The Risk-Based Data Management Revolution
Your RBQM Benchmark Analysis: Prepare for ICH E6 R3
CluePoints Intelligent Analytics Platform
Achieving Success in a Phase 3 Dermatology Study with the Power of Effective RBQM
Using CluePoints to Reveal Protocol Deviations in Patient Selection
The Value of the CluePoints Solution in Identifying Under-reported Adverse Effects in a Clinical Trial
Using CluePoints to Detect Miscalibrated Equipment in a Clinical Trial
Using CluePoints to Identify Fraud Due to the Fabrication of Patient Diaries
Using CluePoints to Identify Severe Propagation in Vital Sign Measurements
Using CluePoints to Detect Anomalies in Electronic Patient-Reported Outcomes
How CluePoints Detected Fraudulent Reporting of Investigational Product Administration from Patient Diary Data
Leveraging Risk-Based Quality Management to Facilitate Early Risk Detection
How CluePoints Enabled Pfizer’s ‘Hyperspeed’ Vaccine Development
Examining the Current State of ICH E6 (R2) Adoption
From RBM to RBQM: The Future of Risk-Based Trial Management
Harnessing CSM to Drive Risk-Based Quality Management (RBQM)
Conclusions from Executive Roundtable on Response to ICH E6 (R2)
Implementing a Scalable Risk-Based Monitoring Strategy
Sponsor Responses to the ICH E6 Revisions
The Principles of Central Statistical Monitoring
Ensuring Trial Validity by Data Quality Assurance and Diversification of Monitoring Methods
All you need to know about SMART™, the Engine that Drives CluePoints
Impact of On-Site Initiation Visits on Patient Recruitment and Data Quality in a Randomized Trial of Adjuvant Chemotherapy for Breast Cancer
Data Fraud in Clinical Trials
Does Central Monitoring Lead to Higher Quality? An Analysis of Key Risk Indicator Outcomes
Detection of Fraud in a Clinical Trial Using Unsupervised Statistical Monitoring
Applying Risk-Based Quality Management To Investigator-Led Trials
From Risk-Based Monitoring To Risk-Based Quality Management
Webinar: The Future Of Clinical Trial Monitoring
New Paper: From RBM To RBQM – The Future Of Risk-Based Trial Management
RBQM Doesn’t Have To Be Complicated, Risky Or Expensive: Q&A
Beyond COVID-19: The New Normal In Risk-Based Monitoring (RBM) And Quality Management (RBQM)
Early Risk Detection During The COVID-19 Crisis – Your Questions Answered
Complimentary COVID-19 Risk Assessment Package Available To All At No Cost
Risk-Based Quality Management – It’s Now A Question Of “How” Rather Than “If”
Implementing A Risk-Based Quality Management Strategy – The Ultimate Guide
Transitioning From A Risk-Based Monitoring Approach To Risk-Based Quality Management
Risk-Based Study Execution (RBx) – It’s Time To Close The Loop!
Site Profile & Oversight Tool (SPOT)
Business Intelligence (BI)
Central Statistical Monitoring
Duplicate Patients
Key Risk Indicators (KRIs)
Patient Profiles
Quality Tolerance Limits (QTLs)
Risk Assessment & Mitigation
Signals & Actions Tracker
How Effective RBQM Transforms CRO Operations
Your Journey to Adaptive Site Monitoring
Medical & Safety Review (MSR)
RBQM Implementation Tip Sheet
Risk-Based Quality Management (RBQM)
Site Profile & Oversight Tool (SPOT)
Intelligent Medical Coding
CluePoints Overview